Completed PHASE3 INTERVENTIONAL 2-arm NCT02806713

The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study) (EPIPhANy)

The Effect of Oral phenazopyrIdine on Perioperative Voiding After Mid-urethral Sling

Sponsor: University of Massachusetts, Worcester

Conditions Dysfunctional Voiding Postoperative Pain

Interventions Phenazopyridine no Phenazopyridine

Updated 9 times since 2017 Last updated: Jan 11, 2019 Started: Feb 29, 2016 Primary completion: Aug 31, 2017 Completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Dysfunctional Voiding and Postoperative Pain and is currently completed. University of Massachusetts, Worcester leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Mar 2019 — Jan 2021 [monthly]

Completed PHASE3
Jul 2018 — Mar 2019 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jun 2018 — Jul 2018 [monthly]

Completed PHASE3
May 2018 — Jun 2018 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Mar 2017 — May 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Mar 2017 [monthly]

Recruiting PHASE3

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Massachusetts, Worcester

Data source: University of Massachusetts, Worcester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Worcester, United States